JAK-inhibition in Recurrent Classical Hodgkin Lymphoma

NCT02164500 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Cologne